[Treatment of allergic diseases with a stimulating antihistaminic compound (plimasina)].
D018926:Anti-Allergic Agents; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006967:Hypersensitivity / Q000628:therapy*; D007154:Immune System Diseases; D010880:Piperidines / Q000627:therapeutic use*; D014309:Tripelennamine / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D010880:Piperidines; D014309:Tripelennamine
ALLERGY/therapy; ANALEPTICS/therapeutic use; ANTIHISTAMINICS/therapeutic use; PIPERIDINES/therapeutic use; TRIPELENNAMINE/therapeutic use
Tratamiento de las alergosis con una asociación antihistamínico estimulante (plimasina).